The staining of the basal ganglia in various conditions not associated with iso-mm on has aroused much interest in recent years. With the introduction of replacement transfusion in the treatment of haemolytic disease, kerikterus due to this dises has become a comparative rarity.
Kernikterus has been described associated with achohlric family jaundice, idiopathic familial hyperbilirubinaemia, and in 1950 two groups of workers, Aidin, Corner and Tovey in Great Britain and Zuelzer and Mudgett in America, independently drew attention to the fact that kermikterus was sometimes associated with prematurity only.
The clinical picture of the premature infant who becomes jaundiced on the third or fourth day of life and by the sixth day exhibits profound jaundice, disinclination to feed, head retraction, changes in muscle tone and cyanosis, and in most cases dies on the sixth or seventh day have been described by Aidin et aL (1950) , and more recently by Crosse, Meyer and Gerrard (1955) .
The post-mortem appearances of kernikterus have aroused much speculation as to the metabolism of the breakdown products of haemoglobin and the pathogenesis of the disease. It has been suggested that bilirubin is the sole cause of the damage to the basal nuclei (Pickles, 1949; Kiister and Krings, 1950) whilst other workers have claimed that it is due to some abnormal pigment such as mesobilifuchsin which arises from an underlying metabolic disorder (Schmorl, 1904; Bevis, 1953) . The suggestions have been made too that the primary lesion may be asphyxial with a secondary bilirubin invasion (Govan and Scott, 1953; Aidin et al., 1950) or the combination of hyperbilirubinaemia and hypoglycaemia Frohlich and Mirsky (1942) . An interesting observation of these latter workers has been their inability to produce staining in animals of over 10 days old.
There is circumstantial evidence which supports the view that bilirubin crosses from the circulation into the cerebral tissue with comparative ease in the newborn (Dereymaeker, 1949; Dine, 1954) . It has been shown by Mollison and Cutbush (1951) that kernikterus seldom occurs in infants affected by haemolytic disease if the serum bilirubin levels do not rise above 18 to 20 mg. %.
It appears that bilirubin is likely to be the causative factor of kernikterus, whatever the mode of production of the hyperbilirubinaemia.
A search of the literature revealed very little information on the normal serum bilirubin levels in the full-term and premature infant. Davidson, Merritt and Weech (1941) , doing daily bilirubin estimations on 94 newborn infants (no mention was made of maturity or weight), produced a normal curve rising to 4 8 mg. on the second day and then falling. They found that there was a very wide deviation of normal, but they correlated their bilirubin levels in the first 10 days of life with those of cord bilirubin levels and stated that the higher the cord bilirubin level the higher the serum level would rise on succeeding days. Other workers have been unable to confirm this. Davidson found also that where the levels rose high they were reached on the fourth day and were about 12 5 mg. per 100 ml.
Obrinsky, Allen and Anderson (1954) Billing, Cole and Lathe (1954) estimated the plasma bilirubin levels in 49 babies whose weights varied from 21 to 1(4 lb. They divided these into 1 lb. weight groups and showed that the smallest babies reached the highest levels (up to 14 mg. per 100 ml.) on the sixth day, whereas the larger ones rose only to 2 5 mg. and usually on the second day.
McLean, Lucey and Harris (1955) have studied the serum bilirubin levels on 60 premature infants and the relationship of these levels to the degree of kernikterus in those who did not survive. They report the levels reached in the four babies with kernikterus in the absence of iso-immunization as being 22 8 mg., 13 2 mg., 15 2 mg. and 12-6 mg. per 100 ml. respectively. They make the interesting observation that there is a remarkable drop in the serum bilirubin levels immnediately preceding death. This has been noted too by Hsia (1954) Parale Investigation A further series was running concurrently in another unit. This consisted of 46 babies of whom five were affected. Serum and C.S.F. estimations of bilirubin were done on various days during the first week of life. It was found fairly early in this series that unless clinical jaundice was marked there was no detectable bilirubin in the C.S.F. so the latter part of this phase was restricted to babies showing marked jaundice and is, therefore, largely selected. All babies in Phases 1 and 2 who developed signs of kernikterus were submitted to lumbar puncture and the bilirubin level estimated in the spinal fluid: these babies were added to this series. Eleven babies in all developed kemikterus and were included in this investigation.
Iso-immunization was excluded serologically in all cases developing kernikterus.
NMethods
Venous samples of blood were collected by syringe from the femoral vein in all cases and allowed to clot and retract for two to four hours in dry centrifuge tubes at room temperature. The quantity of bilirubin in the serum was estimated by van den Bergh's reaction using a slight modification of the technique of Malloy and Evelyn (1937) in which total bilirubin is determined by treatment with diazotized sulphanilic acid in aqueous methanol solution, without precipitation of the proteins. A measure of the direct bilirubin is obtained by carrying out a parallel determination in which water is used in place of methanol. Because of the difficulty of obtaining pure bilirubin an artificial standard was used, consisting of a solution of methyl red at pH 4 63 (King and Coxon, 1950 The quantity of indirectly reacting bilirubin was obtained by subtraction of the directly reacting figure from the total.
Estimations of Bilinruin in C.S.F. Cerebrospinal fluid, I ml., was added to 2 ml. buffer and to this was added I ml. of mixed diazo reagent and 4 ml. methanol as for serum dilutions. No blank was done and total bilirubin colour was measured against water. The calculation was:
Test 0 4 x 8 mg. bilirubin per 100 ml. C.S.F.
Standard
In no case was there more than 3-2 mg. of directly reacting pigment and this only in some of the mature babies showing very small quantities of bilirubin. The quantities of directly reacting pigment were usually less than 2 mg. and as these substances are not considered toxic the levels were disregarded. The total bilirubin in the C.S.F. was estimated as the figures were so low that differentiation was difficult and without significance.
Results Fig. 1 shows the average serum bilirubin levels in the 93 babies in Phase 1 who did not develop kernikterus. They are split into 500 g.-birth-weight groups and the averages calculated and plotted. This figure shows a definite difference in the trend of the curves. The bilirubin levels of babies weighing less than 2,000 g. at birth are still tending to rise on the sixth day, whilst those of the babies in the weight group 2,000-2,500 g. are levelling out and those of the larger babies are falling by the sixth day. Tthe babies in the highest weight group, i.e., over 3,500 g., reach their highest bilirubin levels on the second day and these have dropped by the fourth. Fig. 2 shows the weight group 2,500-3,000 g. The lowest curve is the average of the 12 babies in that weight group. The top curve is the statistically calculated maximum limits and the middle curve shows the maximum readings we obtained from the babies in that weight group.
Maximal statistical normals were calculated for all weight groups and are plotted in Fig. 3 . The curves are similar to those in Fig. 2 D-2,500-3,000 g. (5 lb. 8 oz.-6 lb. 10 oz.). E 3,000-3,500 g. (6 lb. 10 oz.-7 lb. 10 oz.). F-over 3,500 g. (7 lb. 10 oz.). gives the lowest curve of the three groups of premature babies, although the average readings for this group were the highest curve. This is of importance in that there may well be a lower serum bilirubin Two infants who died of kernikterus with levels below 18 mg. per 100 ml. weighed 2 lb. and 2 lb. 8 oz. respectively. They both collapsed suddenly on the sixth day, the collapse being the first sign of the condition apart from the jaundice which had not been thought to be severe. Following the collapse both babies were moribund until they died about six hours later. The samples were taken shortly before death in both cases when the bilirubin level may have been dropping rapidly. One baby had a high level of bilirubin (11 3 mg. per 100 ml.) on his third day and the inference is that the level had been very much higher in the period between the collection of the two specimens. premature babies submitted to lumbar puncture in the first week of life who did not develop kernikterus and the 11 babies who did. The figure is interesting in that it shows samples taken from four babies who had serum bilirubin levels of over 18 mg. per 100 ml. and did not develop signs of kernikterus. At this time it was of interest to find out how high the serum biirbin levels could rise without signs of kemikterus developing. Fig. 6 shows the C.S.F. levels of bilirubin in the same 52 babies. There is on the whole a higher level of bilirubin in the C.S.F. of infants developing kernikterus than in the unaffected ones, but there is no correlation between the C.S.F. level of bilirubin and the appearance of signs of kernikterus. It is not yet known exactly how the conversion of the bilirubin to the directly-reacting pigments takes place in the liver, but presumably the enzyme system responsible is synthesized in the immature liver in response to some stimulus which may well be the level of bilirubin itself. The less mature the liver the higher the bilirubin must rise before it is sufficient to stimulate production of the enzyme. If this hypothesis be true it should be possible to isolate the enzyme or some substance containing the enzyme which may then prevent the hyperbilirubinaemia.
The work of Day (1954) suggests a third possibility in the treatment of hyperbilirubinaemia. He showed that the bilirubin may be oxidized in vitro by cytochrome C and methylene blue, and thereby reversed the effect on the oxygen uptake of rat cerebral tissue. A similar compound with less toxic effects may be synthesized and injected into a jaundiced premature baby.
Replacement transfusion is, however, a recognized form of treatment of hyperbilirubinaemia in haemolytic disease and seems to offer the only method at present available by which toxic levels of bilirubin may be prevented and thus reduce the neonatal mortality and morbidity rate.
The present study shows the curves of serum bilirubin levels on 93 babies of all weight groups and indicates that babies under 2,000 g. (4 lb. 6 oz.) have levels still rising on the sixth day, babies of 2,000 to 2,500 levelling out and levels of babies over 2,500 g. are falling by the sixth day.
Premature babies developing kernikterus have generally higher serum levels of bilirubin and the majority have levels of over 18 mg. % at the onset of signs. Kernikterus is very likely to occur where serum levels of bilirubin rise above 18 mg. %.
There appears to be no critical level of bilirubin in the C.S.F. at which staining of basal nuclei takes place and there is no correlation between the bilirubin levels in the serum and that in the C.S.F.
It is suggested that all jaundiced premature babies should have serial bilirubin estimations, the frequency of those estimations depending on the level of biirubin and the rate of rise of that level.
It is suggested further that replacement transfusion may be effective in the prevention of kemikterus in babies whose serum bilirubin levels are above 18 mg. % or whose rate of rise is rapid.
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